PFIZER INC.

Lobbying client · District of Columbia · filed 2025 to 2026

Biopharmaceutical company.

$260,000 Reported spend

6 Filings counted

1 Firms hired

5 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (57633), not by name.

Firms hired 1

TODD STRATEGY GROUP $260,000 6 filings

Bills named in these filings 5

HR 2214
DRUG Act

5 filings
S 1040
Drug Competition Enhancement Act

3 filings
S 1041
Affordable Prescriptions for Patients Act

3 filings
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…

2 filings
S 832
EPIC Act of 2025

2 filings

Reported by year 2 years

2026 $120,000 2 filings
2025 $140,000 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

Centers For Medicare and Medicaid Services (CMS) 5
Health & Human Services, Dept of (HHS) 5
HOUSE OF REPRESENTATIVES 5
SENATE 5
White House Office 2

Recent filings 6 total

Q2

TODD STRATEGY GROUP

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026

View → Q1

TODD STRATEGY GROUP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 20, 2026

View → Q4

TODD STRATEGY GROUP

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Mar 17, 2026

View → Q3

TODD STRATEGY GROUP

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $60,000 income · posted Mar 17, 2026

View → Q2

TODD STRATEGY GROUP

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $20,000 income · posted Mar 17, 2026

View → RA

TODD STRATEGY GROUP

2nd Quarter (Apr 1 - June 30) 2025 · posted Mar 17, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.